Latest News Headlines
|
Once Trained to Kill, Now Learning to Heal
Tuesday, September 30, 2008 - 07:12 AM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines An Australian medical student's life experiences intermingle with his medical training, producing vivid stories on his blog. Medscape Med Students |
|
Cardinal Health to Spin off 2 Segments as Public Co
Tuesday, September 30, 2008 - 07:10 AM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines Drug wholesaler Cardinal Health Inc said it would spin off its clinical and medical products businesses as a separate public company, and reaffirmed its outlook for fiscal 2009. The company also said Chief Executive Kerry Clark would continue through the spin-off and then retire. Reuters Health Information |
|
FDA Once Again Postpones Decision on Prasugrel
Monday, September 29, 2008 - 01:59 PM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines FDA continues its review of Prasugrel. Heartwire |
|
Bye bye to Boston’s Canadian drug importation program
Monday, September 29, 2008 - 01:20 PM - 3 months, 1 week ago - Blog - Health Business Blog Mayor Menino and health care have a funny relationship. He’s against Minute Clinics in drug stores –for reasons that escape me. He’s also seemingly in favor of drug reimportation from Canada, yet his program to encourage it was ill-conceived and is now being abandoned. Boston made Canadian drug reimportation an option for some of its retirees but almost none took up the offer. It seems the culprits are poor publicity and a lack of incentives provided to the retirees to give it a go. The much smaller city of Springfield, MA has saved about $3 million per year through its reimportation program but Boston’s only captured $4300! What a joke. Now the program is ending . Truth be told there is little reason these days for seniors to turn abroad for drugs. Generic equivalents (or therapeutic substitutes) are available for more drugs, the Canadian dollar is stronger than it used to be, Medicare Part D provides seniors with coverage they used to lack, and safety scares on overseas drugs are all factors. Still, Boston continues to live down to its poor reputation for governance. |
|
Health Spending May Have to Slow as Economy Stalls
Monday, September 29, 2008 - 07:50 AM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines Spending on healthcare may have to slow as Western economies stall, bringing to an end a period in which expenditure has far outstripped growth in GDP, a leading health policy expert said on Friday. Reuters Health Information |
|
Gates Gives $168 Mln for Malaria Vaccines Research
Monday, September 29, 2008 - 07:46 AM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines Microsoft founder Bill Gates gave $168.7 million to develop vaccines for malaria, part of $3 billion in funding announced on Thursday to tackle Africa's biggest killer disease. Reuters Health Information |
|
Fifth of UK Emergency Care Services Told to Improve
Monday, September 29, 2008 - 07:31 AM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines A fifth of emergency care services in England are performing below standard and need to improve, an independent health watchdog said on Friday. Reuters Health Information |
|
FDA Classifies Medtronic's Notice as Class I Recall
Monday, September 29, 2008 - 07:27 AM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines Medtronic Inc said on Friday that U.S. health regulators classified its safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems as a Class I recall. Reuters Health Information |
|
Highly Promising Phase III Trial of Baxter's IVIg for Alzheimer's Disease Begins
Monday, September 29, 2008 - 04:01 AM - 3 months, 1 week ago - Newspaper & TV news - GLG News(sm): Healthcare Not surprisingly, everything tried thus far to slow the relentless progression of Alzheimer's disease has failed. But if strong efficacy signals from two pilot studies and a recently completed Phase II trial of human immunoglobulin (IVIg) are confirmed in a Phase III trial scheduled to start next month, that string of failures will be coming to an abrupt end. The two NIH-supported pivotal trials will answer two questions: (1) is an age-related failure of natural antibody-mediated immunity important in the development of Alzheimer's disease, and (2) can this disease process be slowed by restoring therapeutic levels of antibodies that some older people no longer make enough of? With what we know about the role of beta-amyloid protein in Alzheimer's, and have learned from studies testing anti-beta amyloid monoclonal antibodies, and have seen in those three small IVIg trials , I wouldn't bet on another failure this time around. |
|
Medicare Warns of Part D Changes
Friday, September 26, 2008 - 02:19 PM - 3 months, 1 week ago - Newspaper & TV news - Medscape Business of Medicine Headlines Seniors are urged by officials to check their 2009 drug coverage. WebMD Health News |
< 1 – 2 – 3 – 4 – 5 – 6 – 7 – 8 – 9 – 10 – 11 – 12 – 13 – 14 – 15 – 16 – 17 – 18 – 19 – 20 – 21 – 22 – 23 – 24 – 25 – 26 – 27 – 28 – 29 – 30 – 31 – 41 – 51 – 61 – 71 – 81 >
There are 1 unlogged user and 0 registered users online.
You can log-in or register for a user account here.
You can log-in or register for a user account here.
Preferred language:
